The Lancet Infectious Diseases in conversation with

EXPLORE

Society & Culture

Religion & Spirituality

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/89/d6/59/89d659f6-842b-f713-172e-276b137a7250/mza_13591906078518338376.jpg/600x600bb.jpg

The Lancet Infectious Diseases in conversation with

The Lancet Group

121 episodes

6 days ago

Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship. Read the Series papers: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25...

Show more...

Health & Fitness,

All content for The Lancet Infectious Diseases in conversation with is the property of The Lancet Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship. Read the Series papers: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25...

Show more...

Health & Fitness,

Episodes (20/121)

The Lancet Infectious Diseases in conversation with

Lilian Tina Minja and Norbert Heinrich on TB drug development

Lilian Tina Minja and Norbert Heinrich discuss a pair of trials they recently published in The Lancet Infectious Diseases, ‘A prospective, randomised, open label phase 2b dose-finding trial of sutezolid in combination with bedaquiline, delamanid and moxifloxacin for pulmonary tuberculosis: SUDOCU’ and ‘A prospective, randomised, open label phase 2b dose-finding trial of delpazolid in combination with bedaquiline, delamanid and moxifloxacin for pulmonary tuberculosis: DECODE’ and the wider imp...

1 day ago

29 minutes

The Lancet Infectious Diseases in conversation with

Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile

Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond. Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)0...

1 month ago

15 minutes

The Lancet Infectious Diseases in conversation with

Jan Felix Drexler and Fernando Bozza on Oropouche virus

Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_tlv_podcast_14-04-25_laninf Continue this conversation o...

2 months ago

35 minutes

The Lancet Infectious Diseases in conversation with

Prasad Kulkarni on dengue monoclonal antibodies

Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.Read the full article:https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninfContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://insta...

1 year ago

18 minutes

The Lancet Infectious Diseases in conversation with

Oriol Mitjà on treatment of early syphilis in adults

Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninfContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://insta...

1 year ago

15 minutes

The Lancet Infectious Diseases in conversation with

Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique

Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninfContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgro...

1 year ago

24 minutes

The Lancet Infectious Diseases in conversation with

Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections

Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.Read the full article:Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, BrazilContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://f...

2 years ago

17 minutes

The Lancet Infectious Diseases in conversation with

Richard Maude on malaria chemoprophylaxis in Cambodia

Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.Read the full article:Antimalarial chemoprophylaxis for forest goers in southeast AsiaContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

2 years ago

12 minutes

The Lancet Infectious Diseases in conversation with

Ben Cowling on COVID-19 vaccines in Hong Kong

Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.Read the full article:Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong KongContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://y...

2 years ago

20 minutes

The Lancet Infectious Diseases in conversation with

Hugh Adler on monkeypox in the UK

Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.Read the full article:Clinical features and management of human monkeypox: a retrospective observational study in the UKContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://li...

3 years ago

18 minutes

The Lancet Infectious Diseases in conversation with

Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs

Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.Read the full Series:https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelanc...

3 years ago

22 minutes

The Lancet Infectious Diseases in conversation with

Laura Cooper and Sam Okiror on polio eradication in Africa

A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

3 years ago

21 minutes

The Lancet Infectious Diseases in conversation with

Paul Chapman on a hookworm vaccine

Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancetht...

3 years ago

20 minutes

The Lancet Infectious Diseases in conversation with

Josep Llibre on preventing SARS-CoV-2 transmission at concerts

Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

4 years ago

8 minutes

The Lancet Infectious Diseases in conversation with

Yap Boum on COVID-19 testing in low resource settings

Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

4 years ago

11 minutes

The Lancet Infectious Diseases in conversation with

Antimalarial resistance in southeast Asia

Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East AsiaContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

5 years ago

13 minutes

The Lancet Infectious Diseases in conversation with

Trial in phage therapy for burn infections

A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

6 years ago

29 minutes

The Lancet Infectious Diseases in conversation with

Pandemic influenza: 100 years

Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

7 years ago

18 minutes

The Lancet Infectious Diseases in conversation with

Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018

Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

7 years ago

14 minutes

The Lancet Infectious Diseases in conversation with

MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018

John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

7 years ago

12 minutes